Stock Earnings

Question 1

What are Eledon Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Eledon Pharmaceuticals Inc has a total asset of $177, Net loss of $-36

Question 2

What are the key financial ratios for ELDN?

Accepted Answer

Eledon Pharmaceuticals Inc's Current ratio is 3, has a Net margin is 0, sales per share of $0.

Question 3

How is Eledon Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Eledon Pharmaceuticals Inc data is not available.

Question 4

Is Eledon Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Eledon Pharmaceuticals Inc has a net loss of $-36

Question 5

Does Eledon Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Eledon Pharmaceuticals Inc has liability of 59

Question 6

How many outstanding shares for Eledon Pharmaceuticals Inc?

Accepted Answer

Eledon Pharmaceuticals Inc has a total outstanding shares of 59.78

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	19	18	12	12	13	10
Research & Development	66	51	30	27	23	6
Operating Expenses	86	70	43	39	36	16
Other Non Operating Income (Expenses)	7	34	-73	0	0	-4
Pretax Income	-79	-35	-116	-87	-36	-23
Income Tax Expense	--	0	0	0	-2	0
Net Income	-10	-36	-116	-87	-34	-22
Net Income Growth	-90%	-69%	33%	156%	55%	38%
Shares Outstanding (Diluted)	77.15	48.54	24.61	14.29	14.82	1.45
Shares Change (YoY)	48%	97%	72%	-4%	922%	120%
EPS (Diluted)	-0.13	-0.74	-4.73	-6.16	-2.33	-15.72
EPS Growth	-93%	-84%	-23%	164%	-85%	-35%
Free Cash Flow	-67	-47	-39	-28	-28	-15
Free Cash Flow Per Share	-0.86	-0.96	-1.58	-1.95	-1.88	-10.34
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	-36	-16
EBITDA Margin	--	--	--	--	0%	0%
D&A For EBITDA	--	--	--	--	0	0
EBIT	-86	-70	-43	-39	-36	-16
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%	5.55%	0%

Eledon Pharmaceuticals Inc (ELDN) Price